NEW DELHI, (Reuters) -The drug company Viatris announced on December 23 that the U.S. Food and Drug Administration (FDA) has restricted imports of 11 products made at its facility in Indore, following ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback